tradingkey.logo

Treace Medical Concepts Inc

TMCI
View Detailed Chart

7.190USD

+0.150+2.13%
Close 09/18, 16:00ETQuotes delayed by 15 min
453.27MMarket Cap
LossP/E TTM

Treace Medical Concepts Inc

7.190

+0.150+2.13%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.13%

5 Days

-3.36%

1 Month

+2.13%

6 Months

-14.71%

Year to Date

-3.36%

1 Year

+31.20%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
104 / 207
Overall Ranking
262 / 4721
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 6 analysts
Buy
Current Rating
8.700
Target Price
+23.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.60% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 30.20.
Fairly Valued
The company’s latest PE is -9.17, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 55.28M shares, decreasing 27.13% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.73M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Ticker SymbolTMCI
CompanyTreace Medical Concepts Inc
CEOMr. John T. Treace
Websitehttps://www.treace.com/
KeyAI